Valerio Therapeutics
25 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors (NCT06257758) | Valerio Therapeutics | 2024-01-10 |
| Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors (NCT05700669) | Valerio Therapeutics | 2023-02-20 |
| AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors (NCT03579628) | Valerio Therapeutics | 2018-04-05 |
Track Valerio Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.